The PhyMed Board
Mr. Ferrara was appointed to the Board by Ontario Teachers’ Pension Plan (OTPP) in November 2014. Mr. Ferrara joined TPC in 2006 after spending more than a decade in banking and M&A/corporate development at a private equity backed global enterprise.
He has participated in investments in PhyMed, Heartland Dental, CTVglobemedia, Grupo Corporativo Ono, Avaya Inc., GNC, PhyMed Healthcare Group and Flexera Software. He currently sits on the boards of Heartland Dental. Mr. Ferrara holds a B.Sc. (Honours) and an MBA from the University of Toronto (Rotman). He is a Chartered Accountant and a Chartered Business Valuator.
Marty Bonick has over 20 years of leadership experience in both for-profit and non-profit settings. Prior to joining PhyMed, Mr. Bonick was president of division operations at Community Health Systems (CHS), overseeing a $4.5 billion portfolio of 36 hospitals and their associated clinics, outpatient centers, ambulatory surgery centers and urgent care operations across six states.
Mr. Bonick also served as CEO of Jewish Hospital and Senior Vice President of Operations for Jewish Hospital & St. Mary’s Healthcare in Louisville, KY. He has also held various leadership positions at Ardent Health Services, including CEO of Oklahoma State University Medical Center and VP of Operations for Hillcrest Medical Center in Tulsa, OK.
Mr. Breckon was appointed to the Board by Ontario Teachers’ Pension Plan (OTPP) in November 2014. Mr. Breckon has over 20 years of operating and M&A experience in the global health and life sciences sector, including diagnostics, drug development services, instrumentation, nuclear medicine and sterilization, having served in a number of senior executive roles at Nordion Inc. (formerly known as MDS Inc.).
He was most recently Senior Vice President, Strategy & Corporate Development at MDS prior to joining TPC in 2010 as a Senior Advisor. He was also previously a Partner at Ernst & Young. Mr. Breckon has been a director of more than a dozen public and privately held companies and investment funds in Canada and the United States and is currently a director of INC Research. Mr. Breckon holds a joint B.Sc. in Commerce/Computer Science from the University of Toronto and is a graduate of Harvard’s Advanced Management Program.
Patrick Forest, MD
A PhyMed Board member, Dr. Forrest has been a physician with Anesthesia Medical Group (AMG) since 1999. He manages PhyMed’s clinical oversight, including operations and quality programs. He has held multiple administrative roles within the practice including Chief of Anesthesia and President of the AMG Board of Directors for six years.
Terry Woodward, PhD
Terry Woodward has served as a member of the PhyMed Board since November 2014. Dr. Woodward currently serves as a Director of Teachers’ Private Capital, which he joined in 2001. Prior to joining Teacher’s, Dr. Woodward held senior positions in corporate development and clinical research and development at privately held biopharmaceutical and medical diagnostic companies in the United States.
Dr. Woodward manages the fund’s private equity transactions in the healthcare sector and oversees growth equity and venture capital sectors. He currently serves as a director of INC Research, PetVet Care Centers and the Healthcare Private Equity Association. He received his Bachelor of Science and Master of Science from Virginia Polytechnic Institute and State University, his Ph.D. from McGill University and his M.B.A. from Michigan State University.
Lee Ferrell, MD
Dr. Ferrell has been a physician with Anesthesia Medical Group (AMG) since 1993, serving on the AMG Board of Directors from 2000 to 2007. He has played a key role in partnering with hospital leaders, establishing the Perioperative Transesophageal Echocardiography Program at Centennial Medical Center and chairing the leadership group in opening the Centennial Heart Center in Nashville in 2001. Dr. Ferrell is Board Certified in Anesthesiology and Perioperative Transesophageal Echocardiography.
Samuel R. Nussbaum, MD
From 2000 to 2016, Dr. Nussbaum served as Executive Vice President, Clinical Health Policy, and Chief Medical Officer for Anthem, where he was the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy.
Among his other positions, he served as Executive Vice President, Medical Affairs and System Integration of BJC Health Care, where he led integrated clinical services and served as President of its medical group and Chairman of its commercial and Medicaid health plans. Dr. Nussbaum served as a professor and clinical group at Harvard Medical School and Massachusetts General Hospital, where he led basic science research, drug discovery, clinical studies, teaching and patient care.
He has been recognized by Modern Healthcare as one of the “50 Most Influential Physician Executives in Healthcare.” Dr. Nussbaum currently serves as Chair of a public-private work group established by the Department of Health and Human Services to develop the framework for alternate payment models to enhance patient-centered care and reduce waste in healthcare. He is also a Professor of Clinical Medicine at Washington University School of Medicine and serves as adjunct professor at the Olin School of Business, Washington University.
Mr. Lopes is currently Chairman of the board at Surgical Solutions, LLC, which provides support services that include technicians, disposables, instrumentation and repairs for minimally invasive procedures.
He is also currently Vice Chair of Ameritox, which offers laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients.
Among his previous positions, Mr. Lopes served as CEO of Ameritox. He also held the role of Senior Vice President and Division President of Coventry Health Care, which offers a variety of health care plans, and CEO of St. Louis Connect Care, which provided outpatient specialty medical services.